LONDON, Jan. 24, 2025 /PRNewswire/ — Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia,…

LONDON, Jan. 24, 2025 /PRNewswire/ — Following the licensing agreement with X4 Pharmaceuticals, Norgine is pleased to see the announcement from X4 today that their Marketing Authorization Application (MAA) for mavorixafor for the treatment of WHIM syndrome (warts, hypogammaglobulinemia,…

WINNIPEG, MB, Jan. 24, 2025 /PRNewswire/ — After an exhaustive nine-month international search, the Board of Directors of the Royal Winnipeg Ballet (RWB) are excited to announce the appointment of an internationally recognized, exceptional leader, Christopher Stowell as its new Artistic…

Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.